Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 22, 2024 08:31 ET | Source: Neuronetics

Aetna Policy Update Expands TMS Availability for Adolescents With Depression

MALVERN, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
July 11, 2024 08:36 ET | Source: Neuronetics

California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults

MALVERN, Pa., July 11, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
July 10, 2024 08:32 ET | Source: Neuronetics

BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents

MALVERN, Pa., July 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
July 01, 2024 08:02 ET | Source: Neuronetics

NeuroStar® Launches Better Me Provider Program Nationwide

MALVERN, Pa., July 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
June 13, 2024 08:31 ET | Source: Neuronetics

NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting

MALVERN, Pa., June 13, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
May 15, 2024 07:32 ET | Source: Neuronetics

Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents

MALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
May 01, 2024 08:31 ET | Source: Neuronetics

NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month

MALVERN, Pa., May 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
April 10, 2024 08:31 ET | Source: Neuronetics

New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital

MALVERN, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
March 25, 2024 08:30 ET | Source: Neuronetics

NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression

MALVERN, Pa., March 25, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
March 07, 2024 08:22 ET | Source: Neuronetics

Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network

MALVERN, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right